ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Youth Smoking Begins To Decline, NCI Says

April 5, 2002

NCI CTEP Approved Trials For the Month of April

April 26, 2013

Includes May issue of Business & Regulatory Report.

May 31, 2002

Orlando Hospital Severs MD Anderson Ties, Forming Center with University of Florida

January 10, 2014

In Brief: Howley, Simone Lead Cancer Policy Board: AMA Campaign Fights Youth Smoking

November 22, 1996

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014